• Viral RIPK3 Degradation and Neddylation

  2026-09-21

  Liu et al. identify a family of orthopoxvirus proteins that recruit host SCF machinery to drive RIPK3 degradation, thereby suppressing necroptosis while reshaping virus-induced inflammation and pathogenesis. The study provides a mechanistic framework for examining ubiquitin-proteasome control of innate immunity and for designing follow-up experiments that distinguish pathway dependence from direct substrate targeting.

• (S)-(+)-Methoprene in Insect JH Assays

  2026-09-21

  Use (S)-(+)-Methoprene to separate juvenile hormone receptor signaling from endogenous hormone biosynthesis in developmental, reproductive, and endocrine-disruption assays. This workflow connects transcription factor Met activation with miRNA–mRNA regulation, while practical controls help resolve dosing, solvent, stage, and stability problems.

• Cytochalasin B: A Causal Actin Assay Guide

  2026-09-20

  Cytochalasin B is more than an actin inhibitor: it is a reversible perturbation tool for testing how cytoskeletal architecture controls cellular entry. This guide translates Spiroplasma infection findings into better assay design, controls, and interpretation.

• 3-Deazaadenosine hydrochloride in HSC Assays

  2026-09-19

  Use 3-Deazaadenosine hydrochloride to impose a controlled SAHH-dependent methylation perturbation while tracking hepatic stellate cell activation, RNA stability, and fibrosis-associated signaling. Its upstream activity complements direct TUBB4B inhibition and helps distinguish broad methyl-metabolism effects from the IGF2BP1–TUBB4B–FAK pathway.

• HyperScribe T7 Cy5 RNA Labeling Kit Guide

  2026-09-18

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit is a 25-reaction Cy5 RNA labeling kit for T7-based in vitro transcription. Its adjustable Cy5-UTP substitution supports fluorescent RNA probe synthesis for in situ hybridization and Northern blot hybridization, while the SARS-CoV-2 reference study provides biological context rather than direct product validation.

• Tacrolimus (FK506) in Stress–Immune Signaling

  2026-09-18

  Explore how Tacrolimus (FK506) can dissect calcineurin-dependent cytokine control alongside metabolic-stress pathways involving AMPK, SQSTM1/p62, and NRF2. This guide translates recent autophagy research into more rigorous assay design for transplantation immunology research and autoimmune disease models.

• Docetaxel Workflows for Chemoresistance Research

  2026-09-17

  Build reproducible Docetaxel and Taxotere assays that connect mitotic arrest with apoptosis and treatment resistance. This workflow combines dose-response design, FOXM1-focused combination testing, and practical troubleshooting for breast, ovarian, gastric, and broader cancer chemotherapy research.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-09-17

  FITC-Concanavalin A (ConA) Conjugate provides direct fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces and tissue samples. It is appropriate for carbohydrate-focused immunofluorescence, microscopy, and flow cytometry, but not for non-glycan targets or assays performed outside the stated storage and handling conditions.

• Rotigotine Transdermal Delivery in PD and RLS

  2026-09-16

  The reference review explains how Rotigotine was developed as a continuously delivered dopamine D2/D3 receptor agonist for Parkinson’s disease and restless legs syndrome. Its central contribution is linking pharmacology, transdermal formulation, pharmacokinetics, and randomized clinical evidence to the rationale for sustained dopaminergic receptor stimulation.

• Pentoxifylline: From cAMP Signal to Assay Insight

  2026-09-16

  Pentoxifylline is a phosphodiesterase inhibitor whose cAMP-dependent effects can reshape inflammatory assay interpretation. This guide connects molecular signaling, age-specific monocyte biology, and practical readout selection to improve mechanistic research decisions.

• IgSF6, ER Stress, and Antibacterial Macrophage Defense

  2026-09-15

  The reference study identifies ER-localized IgSF6 as a regulator of intestinal macrophage stress responses rather than simply a conventional cell-surface immune molecule. Loss of Igsf6 improved resistance to Salmonella infection through IRE1α–XBP1 signaling and reactive oxygen species, but increased susceptibility to DSS-induced colitis, revealing a context-dependent trade-off between antibacterial defense and intestinal homeostasis.

• Cyclophilin A and Cyclosporine Resistance in Mice

  2026-09-15

  The reference study established that cyclophilin A is the principal intracellular mediator of cyclosporine-driven immunosuppression, despite the presence of multiple related cyclophilins. By combining Ppia gene deficiency with cellular, allogeneic, and adoptive-reconstitution experiments, the authors connected drug resistance to impaired calcineurin inhibition and provided a rigorous framework for interpreting ligand-dependent immune suppression.

• TH287 Radiosensitizes CRPC Cells to Radiation

  2026-09-14

  A 2026 study found that the MTH1 inhibitor TH287 increased ionizing-radiation sensitivity in PC-3 and DU-145 castration-resistant prostate cancer cells. The strongest combination effect occurred when irradiation followed TH287 exposure by 12 hours, linking treatment sequence with apoptosis and cell-cycle disruption.

• Clozapine Workflows for Schizophrenia Research

  2026-09-14

  Clozapine offers a practical pharmacological benchmark for receptor profiling, ERK1/2 pathway assays, and dose-sensitive neurotoxicity studies. Used alongside targeted magnetic stimulation, it helps separate broad drug-mediated signaling from region-specific circuit modulation in preclinical schizophrenia research.

• Concanavalin A Targets Conserved Coronavirus N-Glycans

  2026-09-13

  Guo and colleagues identify conserved high-mannose N-linked glycans near the coronavirus spike S2′ cleavage site as a broad antiviral vulnerability. Using fusion, pseudovirus, authentic-virus, biochemical, and animal models, the study shows that concanavalin A blocks spike activation and reduces hCoV-NL63 disease in vivo, while also defining important limitations for translation.

8499 records 1/567 page Next 12345 下5页 Last page